Chemomab Therapeutics (CMMB) Tops Q1 EPS by 0c
Tweet
Share
E-mailGet Alerts CMMB Hot Sheet
Join SI Premium – FREE
Chemomab Therapeutics (NASDAQ: CMMB) reported Q1 EPS of ($0.01), $0.00 better than the analyst estimate of ($0.01).
For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Deere shares climb as fiscal Q3 earnings and revenue top estimates
- Etsy upgraded to buy at BofA on durable growth, buyback potential
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
